On the mechanisms underlying activation and reversal of high altitude-induced pulmonary hypertension in humans - Another piece in the pulmonary puzzle
- PMID: 36409273
- PMCID: PMC10103756
- DOI: 10.1113/EP090967
On the mechanisms underlying activation and reversal of high altitude-induced pulmonary hypertension in humans - Another piece in the pulmonary puzzle
Keywords: Sherpa; endothelin; high altitude; hypoxia; hypoxic pulmonary vasoconstriction; nitric oxide; reactive oxygen species; vascular remodelling.
Conflict of interest statement
D.M.B. is Chair of the Life Sciences Working Group and member of the Human Spaceflight and Exploration Science Advisory Committee to the European Space Agency and is a member of the Space Exploration Advisory Committee to the UK Space Agency. D.M.B. is affiliated to the companies FloTBI, BrainEx and OrgEx focused on the technological development of novel biomarkers of brain injury in humans.
Figures
References
-
- Anand, I. S. , Malhotra, R. M. , Chandrashekhar, Y. , Bali, H. K. , Chauhan, S. S. , Jindal, S. K. , Bhandari, R. K. , & Wahi, P. L (1990). Adult subacute mountain sickness–a syndrome of congestive heart failure in man at very high altitude. Lancet, 335(8689), 561–565. - PubMed
-
- Bailey, D. M. , Dehnert, C. , Luks, A. M. , Menold, E. , Castell, C. , Schendler, G. , Faoro, V. , Gutowski, M. , Evans, K. A. , Taudorf, S. , James, P. E. , McEneny, J. , Young, I. S. , Swenson, E. R. , Mairbaurl, H. , Bartsch, P. , & Berger, M. M (2010). High‐altitude pulmonary hypertension is associated with a free radical‐mediated reduction in pulmonary nitric oxide bioavailability. The Journal of Physiology, 588(23), 4837–4847. - PMC - PubMed
-
- Bartsch, P. , & Swenson, E. R. (2013). Clinical practice: Acute high‐altitude illnesses. New England Journal of Medicine, 368(24), 2294–2302. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
